Literature DB >> 10430499

Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons.

K E McCarson1.   

Abstract

The neurokinin-1 receptor and its tachykinin neuropeptide ligand substance P are associated with the mediation of nociception. Substance P released from primary afferent sensory neurons activates neurokinin receptors on both central and peripheral targets that mediate specific aspects of central sensitization and inflammatory function; however, an autoreceptor function for the neurokinin-1 receptor remains highly controversial. Activation of the neurokinin-1 receptor by substance P during chronic nociception increases neurokinin-1 receptor gene expression in the spinal cord. Similarly, neurokinin-3 receptors on peripheral or target tissues or neurons could play an important role in the sensitization of sensory neurons. Therefore, this study (i) mapped the steady-state levels of substance P-encoding preprotachykinin, neurokinin-1 and neurokinin-3 receptor messenger RNAs in central and peripheral tissues including sensory ganglia, and (ii) investigated whether formalin-evoked nociception altered the quantity or location of neurokinin-1 or neurokinin-3 receptor messenger RNAs in the sensory ganglia or inflamed peripheral targets for substance P. Solution hybridization-nuclease protection assays quantified neurokinin receptor messenger RNA levels in central and peripheral tissues from normal and formalin-inflamed rats. High concentrations of the neurokinin-1 receptor were found in whole brain, spinal cord, and peripheral target organs innervated by substance P-containing neurons. Measurable levels of neurokinin-3 receptor messenger RNA were found only in brain, spinal cord and urinary bladder. Results also show that neither neurokinin-1 nor neurokinin-3 receptor messenger RNAs were detectable in primary afferent sensory neurons in the dorsal root ganglia of normal or formalin-inflamed rats. Neurokinin-1 receptor messenger RNA levels were, however, significantly increased in hindpaw tissues inflamed by formalin for 6 h. These results indicate that the plasticity of neurokinin-1 receptor gene expression in non-neuronal peripheral cells could regulate sensitivity to substance P in a manner similar to that in the spinal cord dorsal horn. Altered neurokinin-1 receptor gene expression provides a useful marker of long-term nociceptive activation and may mediate peripheral mechanisms of hyperalgesia and cellular sensitization during inflammation. Importantly, inflammation does not induce a phenotypic change in afferent sensory neurons providing neurokinin receptor targets for the direct sensitization of these neurons by substance P.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430499     DOI: 10.1016/s0306-4522(99)00102-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Mild Traumatic Brain Injury in Mice Beneficially Alters Lung NK1R and Structural Protein Expression to Enhance Survival after Pseudomonas aeruginosa Infection.

Authors:  Max Vaickus; Terry Hsieh; Ekaterina Kintsurashvili; Jiyoun Kim; Daniel Kirsch; George Kasotakis; Daniel G Remick
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

Review 2.  Work-related musculoskeletal disorders of the hand and wrist: epidemiology, pathophysiology, and sensorimotor changes.

Authors:  Ann E Barr; Mary F Barbe; Brian D Clark
Journal:  J Orthop Sports Phys Ther       Date:  2004-10       Impact factor: 4.751

3.  Activation of silent mechanoreceptive cat C and Adelta sensory neurons and their substance P expression following peripheral inflammation.

Authors:  G Y Xu; L Y Huang; Z Q Zhao
Journal:  J Physiol       Date:  2000-10-15       Impact factor: 5.182

4.  Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity.

Authors:  Catherine Rougeot; Michaël Messaoudi; Véronique Hermitte; Anne Gaëlle Rigault; Thierry Blisnick; Christophe Dugave; Didier Desor; François Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

5.  PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons.

Authors:  Chun-Lei Cang; Hua Zhang; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

6.  Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia.

Authors:  Hua Zhang; Chun-Lei Cang; Yasuhiko Kawasaki; Ling-Li Liang; Yu-Qiu Zhang; Ru-Rong Ji; Zhi-Qi Zhao
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

7.  High force reaching task induces widespread inflammation, increased spinal cord neurochemicals and neuropathic pain.

Authors:  M B Elliott; A E Barr; B D Clark; M Amin; S Amin; M F Barbe
Journal:  Neuroscience       Date:  2008-11-07       Impact factor: 3.590

8.  Peripheral neuritis and increased spinal cord neurochemicals are induced in a model of repetitive motion injury with low force and repetition exposure.

Authors:  Melanie B Elliott; Ann E Barr; David M Kietrys; Talal Al-Shatti; Mamta Amin; Mary F Barbe
Journal:  Brain Res       Date:  2008-04-23       Impact factor: 3.252

9.  PET-scan shows peripherally increased neurokinin 1 receptor availability in chronic tennis elbow: visualizing neurogenic inflammation?

Authors:  Magnus Peterson; Kurt Svärdsudd; Lieuwe Appel; Henry Engler; Mikko Aarnio; Torsten Gordh; Bengt Långström; Jens Sörensen
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

10.  Synthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.

Authors:  Saeed Mozaffari; Mostafa Erfani; Davood Beiki; Fariba Johari Daha; Farzad Kobarfard; Saeed Balalaie; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.